Medicine & TechnologyAn international team of researchers has discovered an immunotherapy method which could add years to healthy aging. Read the article to find out more.
A promising study shows that dostarlimab was effective in phase II clinical trials of a dozen patients with a subset of rectal cancer. Read on to learn more.
CAR T cell immunotherapy is a promising yet expensive form of cancer treatment. Read on to find out how NCSU researchers developed a marshmallow-like scaffold to hasten and cheapen the process.
British scientists could be on the verge of a breakthrough in pancreatic cancer treatment that uses a combination of immunotherapy and soundwaves to blast tumors.
A new study shows that a high fiber diet influences the gut microbiome, which helps melanoma patients to respond better to immunotherapy and improve survival rates.
Two new studies have shown that anti-PD-1 immunotherapy is safe and effective for patients with squamous cell carcinoma and that high immunoscores lead to better outcomes.
Researchers at UPMC Hillman Cancer Center and the National Cancer Institute (NCI) showed how fecal transplants turned patients with melanoma who are non-responders to immunotherapy become responders.
Experts say some patients have significant responses to immunotherapy that last for years. In some circumstances, so many years that it has been thought that these patients may have been treated for their disease.
Cancer immunotherapy refers to a range of procedures that strengthens the patient's own immune system against cancer cells. Unfortunately, other patients do not respond as well.
Scientists from Duke-NUS Medical School in Singapore will use immunotherapy cells used for cancer treatment as a way to eliminate COVID-19. It is a cost-effective method that is already picking up steam.